Literature DB >> 2447294

Ribonuclease activity is associated with subviral particles isolated from interferon-treated vesicular stomatitis virus-infected cells.

R Kumar1, D Chattopadhyay, A K Banerjee, G C Sen.   

Abstract

Previously we have shown that inhibition of replication of vesicular stomatitis virus in interferon-treated JLSV-11 cells is at least partly caused by impaired viral primary transcription. Here we report that subviral particles isolated from interferon-treated infected cells were deficient in mRNA synthesis in vitro compared with the particles isolated from untreated cells. This was due to the presence of an associated ribonuclease activity which hydrolyzed not only newly synthesized viral mRNAs but also exogenously added viral transcripts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447294      PMCID: PMC250584     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Interferon action III. The rate of primary transcription of vesicular stomatitis virus is inhibited by interferon action.

Authors:  P I Marcus; M J Sekellick
Journal:  J Gen Virol       Date:  1978-03       Impact factor: 3.891

2.  Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro.

Authors:  B P De; A K Banerjee
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

Review 3.  Biochemical pathways in interferon-action.

Authors:  G C Sen
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

Review 4.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

5.  Formation and characteristics of reovirus subviral particles in interferon-treated mouse L cells.

Authors:  R L Galster; P Lengyel
Journal:  Nucleic Acids Res       Date:  1976-03       Impact factor: 16.971

6.  Characterization and translation of methylated and unmethylated vesicular stomatitis virus mRNA synthesized in vitro by ribonucleoprotein particles from vesicular stomatitis virus-infected L cells.

Authors:  F Toneguzzo; H P Ghosh
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

7.  Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro.

Authors:  D Chattopadhyay; A K Banerjee
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

8.  Inhibition of vesicular stomatitis viral mRNA synthesis by interferons.

Authors:  L S Belkowski; G C Sen
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  An interferon-induced cellular enzyme is incorporated into virions.

Authors:  D Wallach; M Revel
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

10.  Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease.

Authors:  C Baglioni; A De Benedetti; G J Williams
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

  10 in total
  4 in total

1.  Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  R Kumar; D Choubey; P Lengyel; G C Sen
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Mice deficient in oocyte-specific oligoadenylate synthetase-like protein OAS1D display reduced fertility.

Authors:  Wei Yan; Lang Ma; Paula Stein; Stephanie A Pangas; Kathleen H Burns; Yuchen Bai; Richard M Schultz; Martin M Matzuk
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; A Schuster; M Bayer; J Pavlovic; V ter Meulen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.

Authors:  Bijesh George; Revikumar Amjesh; Aswathy Mary Paul; T R Santhoshkumar; Madhavan Radhakrishna Pillai; Rakesh Kumar
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.